TRT / RTR Design [RSABE / ABEL]

posted by mittyri  – Russia, 2017-05-02 20:38 (3342 d 23:02 ago) – Posting: # 17295
Views: 12,308

Dear Yura,

you should use all data included in PK analysis (ie all subjects) for CI estimation.
To extent the limits you need to calculate variability of RR, that is, 50% of subjects.
A hint: even if you try to calculate variability of RR for overall dataset, the majority of software (at least SAS PHX, R) is smart enough not to include the subjects with one R.

❝ The appropriate sample size must be.

❝ Alpha correction.

what did you mean here?

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
373 visitors (0 registered, 373 guests [including 24 identified bots]).
Forum time: 19:40 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5